Skip to main content


biosimilars

News
December 16, 2020
A recent article outlines challenges that remain regarding the regulatory evaluation of biosimilars and offers potential solutions for the future.
News
December 16, 2020
A recent article outlines challenges that remain regarding the regulatory evaluation of biosimilars and offers…
News
December 11, 2020
A recent policy review identifies factors that prevent the effective launch of oncology biosimilars.
News
JCP Editors, September 21, 2020
A position paper released by the American College of Physicians made concrete policy reform suggestions for…
News
JCP Editors, July 08, 2020
Patients with HER2-positive advanced gastric cancer who are treated with a first-line biosimilar-containing triplet…
News
JCP Editors, June 26, 2020
A cross-sectional survey showed that, while many oncology providers believe biosimilar products to be safe and…
News
JCP Editors, June 19, 2020
Simulation modeling demonstrated that prophylaxis of chemotherapy-induced febrile neutropenia with a supportive care…
News
JCP Editors, June 12, 2020
A study that tracked average reimbursement by CMS for a supportive care biosimilar may have a significant impact on an…
News
JCP Editors, April 30, 2020
Results of a recent survey have led to the identification of various biosimilar learning needs and challenges faced in…
News
JCP Editors, April 16, 2020
A recent analysis evaluated the potential capability of the Biologics and Biosimilars Collective Intelligence…
News
JCP Editors, April 03, 2020
A study at a large academic medical center shed light on a successful biosimilar adoption program, cost-savings…
Back to Top